| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/18/2005 | US6843900 Potentiometric NOx sensors based on yttria-stabilized zirconia with zeolite modified electrode |
| 01/18/2005 | US6843240 Method for monitoring the functioning of a NOx sensor arranged in an exhaust gas channel of an internal combustion engine |
| 01/18/2005 | US6843144 Device for exposing a sample to electromagnetic radiation, for testing the aging of samples |
| 01/18/2005 | US6843104 Sampling system for exhaust gas sensors and method of using same |
| 01/18/2005 | US6843101 CO2 sensor |
| 01/18/2005 | US6843100 Thermal conductivity measurement of carbon dioxide gas with relative humidity and temperature compensation |
| 01/18/2005 | CA2474529A1 Improved fluid mixing in a diagnostic analyzer |
| 01/18/2005 | CA2333686C Method and device for electrochemical immunoassay of multiple analytes |
| 01/18/2005 | CA2311301C Method and apparatus for making quantitative measurements of localized aaccumulations of magnetic particles |
| 01/18/2005 | CA2188660C Detection of mutation by resolvase cleavage |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/18/2005 | CA2074556C Immunological detection method |
| 01/17/2005 | CA2475163A1 Use of lipase for high-density lipoprotein cholesterol detection |
| 01/17/2005 | CA2474952A1 A one-step assay for high-density lipoprotein cholesterol |
| 01/17/2005 | CA2474843A1 Dry analytical element for high-density lipoprotein cholesterol quantification |
| 01/15/2005 | CA2435136A1 Reducing polyglutamine-based aggregation |
| 01/13/2005 | WO2005003821A2 Phase change sensor |
| 01/13/2005 | WO2005003788A1 Centrifugal separator and nucleic acid-analying device using the same |
| 01/13/2005 | WO2005003787A1 Particle agglutination detection method and device |
| 01/13/2005 | WO2005003786A2 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/13/2005 | WO2005003785A2 Anti-inflammatory assay and compounds |
| 01/13/2005 | WO2005003784A1 A method of screening for cell colonies that express a soluble variant of a target protein |
| 01/13/2005 | WO2005003783A1 Methods for identifying compounds interacting with small membrane-bound gtp-ases |
| 01/13/2005 | WO2005003782A1 Secreted polypeptide species reduced in cardiovascular disorders |
| 01/13/2005 | WO2005003781A2 Secreted polypeptide species associated with cardiovascular disorders |
| 01/13/2005 | WO2005003780A2 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 4 (snsr4) |
| 01/13/2005 | WO2005003779A2 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 3 (snsr3) |
| 01/13/2005 | WO2005003778A2 A method for identifying a synthetic molecule having affinity towards a target |
| 01/13/2005 | WO2005003777A2 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences |
| 01/13/2005 | WO2005003776A2 In vitro methods for detecting renal cancer |
| 01/13/2005 | WO2005003775A2 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/13/2005 | WO2005003774A1 Electrochemicalbiosensor test strip and reagent for analyzing physiologicsl sample including blood corpuscles |
| 01/13/2005 | WO2005003773A1 Standard |
| 01/13/2005 | WO2005003772A1 Device and method for identifying an analyte |
| 01/13/2005 | WO2005003771A1 Two-layer antibody capture system |
| 01/13/2005 | WO2005003770A1 Biochemical reaction system, biochemical reaction substrate, process for producing hybridization substrate and hybridization method |
| 01/13/2005 | WO2005003769A1 Bio-chip |
| 01/13/2005 | WO2005003768A1 Protein markers for human benign prostatic hyperplasia (bph) |
| 01/13/2005 | WO2005003767A2 Elemental analysis of tagged biologically active materials |
| 01/13/2005 | WO2005003766A2 Methods of regulating metabolism and mitochondrial function |
| 01/13/2005 | WO2005003765A1 Isothermal titration calorimetry assays |
| 01/13/2005 | WO2005003764A2 Assay for detecting atrial and brain natriuretic peptide prohormones |
| 01/13/2005 | WO2005003763A2 Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3) |
| 01/13/2005 | WO2005003762A2 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 2 (snsr2) |
| 01/13/2005 | WO2005003761A1 Method and system for the detection and recording of adhesive deposits or components in paper and woodpulp production |
| 01/13/2005 | WO2005003760A1 Method and apparatus for analysing combustion products |
| 01/13/2005 | WO2005003759A1 A method for analysis of a beverage |
| 01/13/2005 | WO2005003758A1 Method and device for measuring foam |
| 01/13/2005 | WO2005003756A1 Gas monitoring apparatus |
| 01/13/2005 | WO2005003755A1 Drift compensation for an impedimetric exhaust gas sensor by variable bias voltage |
| 01/13/2005 | WO2005003754A2 Computer-controlled automated titration apparatus for optically determining incompatibility of petroleum oils |
| 01/13/2005 | WO2005003751A1 System and method for coding information on a biosensor test strip |
| 01/13/2005 | WO2005003748A1 System and method for glucose and hematocrit measurement using ac phase angle measurements |
| 01/13/2005 | WO2005003747A1 Microwave resonator, textile machine comprising a resonator of this type, and a dielectric for this resonator |
| 01/13/2005 | WO2005003745A1 Method and system for prediction the color of gemstones |
| 01/13/2005 | WO2005003740A1 Reflectance sensor for measuring liquid pigment preparations or solid pigmented surfaces |
| 01/13/2005 | WO2005003734A1 A method of and apparatus for detecting the presence of signature volatile compounds from materials in a confined environment |
| 01/13/2005 | WO2005003732A2 Diagnostic test for analytes in a sample |
| 01/13/2005 | WO2005003730A2 Sensors |
| 01/13/2005 | WO2005003728A2 Measuring soil light response |
| 01/13/2005 | WO2005003727A2 Optical sensor for measuring characteristics and properties of strands |
| 01/13/2005 | WO2005003723A2 Method for uniform application of fluid into a reactive reagent area |
| 01/13/2005 | WO2005003720A2 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 01/13/2005 | WO2005003716A2 Surface imprinting: integration of molecular recognition and transduction |
| 01/13/2005 | WO2005003715A2 Promoted ionization for secondary ion mass spectrometry |
| 01/13/2005 | WO2005003394A2 Bio-barcode based detection of target analytes |
| 01/13/2005 | WO2005003391A1 Cucurbituril derivative-bonded solid substrate and biochip using the same |
| 01/13/2005 | WO2005003383A1 Improvements in sensor chips |
| 01/13/2005 | WO2005003380A1 Methods for detecting aneuploidy using microparticle multiplex detection |
| 01/13/2005 | WO2005003379A2 Automatic large-scale screening of cells secreting monoclonal antibodies |
| 01/13/2005 | WO2005003376A2 Anthrax antigen vaccine cultures by fluorescence polarization |
| 01/13/2005 | WO2005003372A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003371A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003314A2 A method of selecting an active oligonucleotide predictive model |
| 01/13/2005 | WO2005003306A2 Sppls as modifiers of the p53 pathway and methods of use |
| 01/13/2005 | WO2005003305A2 Usps as modifiers of the beta catenin pathway and methods of use |
| 01/13/2005 | WO2005003303A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003301A2 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 01/13/2005 | WO2005003298A2 Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease |
| 01/13/2005 | WO2005003297A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 01/13/2005 | WO2005003291A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | WO2005003290A2 Methods and devices for determining a cell characteristic, and applications employing same |
| 01/13/2005 | WO2005003176A1 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 01/13/2005 | WO2005003172A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | WO2005003168A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 01/13/2005 | WO2005003164A2 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | WO2005003161A2 Human secreted proteins |
| 01/13/2005 | WO2005003158A2 Compositions and methods for increasing bone mineralization |
| 01/13/2005 | WO2005003155A1 Protein achieving improved blocking efficiency |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005003136A1 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same |
| 01/13/2005 | WO2005002782A1 Method of suppressing extension of fatigue crack, method of detecting fatigue crack, and paste used for the methods |
| 01/13/2005 | WO2005002743A1 Controlled surface-chemical gradients |
| 01/13/2005 | WO2005002618A1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 01/13/2005 | WO2005002614A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | WO2005002551A2 Vanilloid receptor (vr) 1 inhibitors for treatment of human immunodeficiency virus (hiv)-mediated pain states |
| 01/13/2005 | WO2005002527A2 Sirt1 modulation of adipogenesis and adipose function |